Anti-cancer therapies targeting the tumor stroma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 1, doi. 10.1007/s00262-007-0365-5
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 1
Results: 14
1
2
Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 73, doi. 10.1007/s00262-007-0351-y
- By:
- Publication type:
- Article
3
Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 85, doi. 10.1007/s00262-007-0352-x
- By:
- Publication type:
- Article
4
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 123, doi. 10.1007/s00262-007-0336-x
- By:
- Publication type:
- Article
5
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 19, doi. 10.1007/s00262-007-0346-8
- By:
- Publication type:
- Article
6
A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 43, doi. 10.1007/s00262-007-0348-6
- By:
- Publication type:
- Article
7
Immunological profiling of a panel of human ovarian cancer cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 31, doi. 10.1007/s00262-007-0347-7
- By:
- Publication type:
- Article
8
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 97, doi. 10.1007/s00262-007-0353-9
- By:
- Publication type:
- Article
9
Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8<sup>+</sup> T cells against tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 63, doi. 10.1007/s00262-007-0350-z
- By:
- Publication type:
- Article
10
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 107, doi. 10.1007/s00262-007-0358-4
- By:
- Publication type:
- Article
11
HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 53, doi. 10.1007/s00262-007-0349-5
- By:
- Publication type:
- Article
12
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 115, doi. 10.1007/s00262-007-0363-7
- By:
- Publication type:
- Article
13
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
14
Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany.
- Published in:
- 2008
- By:
- Publication type:
- Report